Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ANK3 | Q12955 | Ankyrin-3 (ANK-3) (Ankyrin-G) | Cancer-related genesDisease related genesHuman disease related genes | Autism spectrum disorderIntellectual disability | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 7 | 0.63 | |||
| APOBR | Q0VD83 | Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R) | Predicted intracellular proteins | Atherosclerosis | Fusion and delivery mediation | 7 | 0.63 | |||
| APOD | P05090 | Apolipoprotein D (Apo-D) (ApoD) | Cancer-related genesCandidate cardiovascular disease genesPlasma proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | ||||
| ASAP1 | Q9ULH1 | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) | Predicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 7 | 0.63 | ||||
| CADH6 | P55285 | Cadherin-6 (Kidney cadherin) (K-cadherin) | Plasma proteinsPredicted membrane proteins | 1 | Ovarian cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | ||
| CALD1 | Q05682 | Caldesmon (CDM) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediation | 7 | 0.63 | ||||
| CC038 | Q5JPI3 | Uncharacterized protein C3orf38 | Predicted intracellular proteins | Other mediation | 7 | 0.63 | ||||
| CD19 | P15391 | B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19) | CD markersDisease related genesFDA approved drug targets | 1 | Acute myeloid leukaemiaB-cell lymphomaDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | ||
| CSPG5 | O95196 | Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C) | Predicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | |||
| DSC2 | Q02487 | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | Disease related genesHuman disease related genesPlasma proteins | 1 | Cardiomyopathy | Adhesion and uptake mediationFusion and delivery mediation | 7 | 0.63 |